Yale School of Medicine, Department of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Yale University, New Haven, Connecticut.
Department of Chemistry, Yale University, New Haven, Connecticut.
Am J Physiol Lung Cell Mol Physiol. 2020 Oct 1;319(4):L661-L669. doi: 10.1152/ajplung.00316.2020. Epub 2020 Aug 12.
The past two decades have witnessed a resurgence in neutrophil research, inspired in part by the discovery of neutrophil extracellular traps (NETs) and their myriad roles in health and disease. Within the lung, dysregulation of neutrophils and NETosis have been linked to an array of diseases including pneumonia, cystic fibrosis, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and severe asthma. However, our understanding of pathologic neutrophil responses in the lung remains incomplete. Two methodologic issues have contributed to this gap: first, an emphasis on studying neutrophils from blood rather than the lung and second, the technical difficulties of interrogating neutrophil responses in mice, which has largely restricted basic murine research to specialized laboratories. To address these limitations, we have developed a suite of techniques for studying neutrophil effector functions specifically in the mouse lung. These include ex vivo assays for phagocytosis and NETosis using bronchoalveolar neutrophils and in situ evaluation of NETosis in a murine model of pneumonia. Throughout, we have prioritized technical ease and robust, quantitative readouts. We hope these assays will help to standardize research on lung neutrophils and improve accessibility to this burgeoning field.
在过去的二十年中,中性粒细胞研究出现了复苏,部分原因是发现了中性粒细胞胞外诱捕网(NETs)及其在健康和疾病中的多种作用。在肺部,中性粒细胞和 NETosis 的失调与一系列疾病有关,包括肺炎、囊性纤维化、急性呼吸窘迫综合征(ARDS)、慢性阻塞性肺疾病(COPD)和严重哮喘。然而,我们对肺部病理性中性粒细胞反应的理解仍然不完整。有两个方法学问题导致了这一差距:首先,强调从血液而不是肺部研究中性粒细胞,其次,在小鼠中研究中性粒细胞反应的技术难度很大,这在很大程度上限制了基础小鼠研究只能在专门的实验室进行。为了解决这些限制,我们开发了一系列专门用于研究小鼠肺部中性粒细胞效应功能的技术。这些技术包括使用支气管肺泡中性粒细胞进行吞噬作用和 NETosis 的离体测定,以及在肺炎小鼠模型中对 NETosis 的原位评估。在整个过程中,我们优先考虑技术的简便性和稳健、定量的检测结果。我们希望这些测定方法将有助于标准化肺部中性粒细胞的研究,并提高对这个新兴领域的可及性。